TREM2 acts as a tumor suppressor in hepatocellular carcinoma by targeting the PI3K/Akt/β-catenin pathway.
Oncogenesis. 2019 Jan 25;8(2):9. doi: 10.1038/s41389-018-0115-x.
Oncogenesis. 2019.
PMID: 30683932
Free PMC article.